Innolet 30R Injection, manufactured by Novo Nordisk Pharma, contains insulin human (recombinant). This premixed insulin formulation contains 30% rapid-acting and 70% intermediate-acting insulin, used for managing blood sugar levels in diabetes. It has a YJ code of 2492413G5046 and a standard of 300 units per kit.
Innolet 30R Injection
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →